Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
Trastuzumab-deruxtecan: Pneumocystis jirovecii pneumonia: case reportReactions Weekly, 2023-11, Vol.1984 (1), p.520-520Sem texto completo |
|
2 |
Material Type: Artigo
|
Trastuzumab-deruxtecan: Interstitial lung disease: case reportReactions Weekly, 2023-10, Vol.1979 (1), p.457-457Sem texto completo |
|
3 |
Material Type: Artigo
|
PEG-3350/sodium-chloride/sodium-sulfate/potassium-chloride/ascorbic-acid: Acute oxalate nephropathy: case reportReactions Weekly, 2023-09, Vol.1973 (1), p.236-236Sem texto completo |
|
4 |
Material Type: Artigo
|
Inotuzumab-ozogamicin: Hepatotoxicity: case reportReactions Weekly, 2023-08, Vol.1971 (1), p.138-138Sem texto completo |
|
5 |
Material Type: Artigo
|
Gemtuzumab-ozogamicin: Acute left ventricular dysfunction: 2 case reportsReactions Weekly, 2023-07, Vol.1963 (1), p.261-261Sem texto completo |
|
6 |
Material Type: Artigo
|
Global track and trace systemsReactions weekly, 2021-08 (1869), p.3-3Auckland: Springer Nature B.VTexto completo disponível |
|
7 |
Material Type: Artigo
|
Inotuzumab-ozogamicin: Sinusoidal obstruction syndrome: case reportReactions Weekly, 2023-06, Vol.1960 (1), p.243-243Sem texto completo |
|
8 |
Material Type: Artigo
|
Camrelizumab/rivoceranib: Cytokine release syndrome following off-label use: case reportReactions Weekly, 2023-04, Vol.1953 (1), p.119-119Sem texto completo |
|
9 |
Material Type: Artigo
|
Camrelizumab/rivoceranib: Hypothyroidism: case reportReactions Weekly, 2023-04, Vol.1952 (1), p.111-111Sem texto completo |
|
10 |
Material Type: Artigo
|
Camrelizumab/rivoceranib: Various toxicities: 4 case reportsReactions Weekly, 2023-01, Vol.1939 (1), p.126-126Sem texto completo |